265 related articles for article (PubMed ID: 19427027)
21. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Hsieh DS; Lin YF; Wang JY; Sheu LF; Lee WH
Int J Urol; 2006 May; 13(5):573-80. PubMed ID: 16771728
[TBL] [Abstract][Full Text] [Related]
22. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
[TBL] [Abstract][Full Text] [Related]
23. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.
Chen L; Nakai M; Belton RJ; Nowak RA
Reproduction; 2007 Feb; 133(2):405-14. PubMed ID: 17307908
[TBL] [Abstract][Full Text] [Related]
24. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix metalloprotease inducer-expressing head and neck squamous cell carcinoma cells promote fibroblast-mediated type I collagen degradation in vitro.
Rosenthal EL; Zhang W; Talbert M; Raisch KP; Peters GE
Mol Cancer Res; 2005 Apr; 3(4):195-202. PubMed ID: 15831673
[TBL] [Abstract][Full Text] [Related]
26. EMMPRIN and MMP-1 in keratoconus.
Seppälä HP; Määttä M; Rautia M; Mackiewicz Z; Tuisku I; Tervo T; Konttinen YT
Cornea; 2006 Apr; 25(3):325-30. PubMed ID: 16633034
[TBL] [Abstract][Full Text] [Related]
27. EMMPRIN (basigin/CD147) expression is not correlated with MMP activity during adult mouse mammary gland development.
Szymanowska M; Hendry KA; Robinson C; Kolb AF
J Cell Biochem; 2009 Jan; 106(1):52-62. PubMed ID: 19003972
[TBL] [Abstract][Full Text] [Related]
28. High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters.
Hakuma N; Betsuyaku T; Kinoshita I; Itoh T; Kaga K; Kondo S; Nishimura M; Dosaka-Akita H
Oncology; 2007; 72(3-4):197-204. PubMed ID: 18160808
[TBL] [Abstract][Full Text] [Related]
29. EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes.
Siwik DA; Kuster GM; Brahmbhatt JV; Zaidi Z; Malik J; Ooi H; Ghorayeb G
J Mol Cell Cardiol; 2008 Jan; 44(1):210-7. PubMed ID: 17869266
[TBL] [Abstract][Full Text] [Related]
30. Extracellular matrix metalloproteinase inducer is expressed in the proximal tubular epithelial cells of the human kidney.
Shimada M; Yamabe H; Osawa H; Nakamura N; Kumasaka R; Murakami R; Fujita T; Osanai T; Okumura K
Nephrology (Carlton); 2009 Apr; 14(2):171-8. PubMed ID: 19019167
[TBL] [Abstract][Full Text] [Related]
31. Expression and clinical significance of CD147 in genitourinary carcinomas.
Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
[TBL] [Abstract][Full Text] [Related]
32. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.
Gabison EE; Hoang-Xuan T; Mauviel A; Menashi S
Biochimie; 2005; 87(3-4):361-8. PubMed ID: 15781323
[TBL] [Abstract][Full Text] [Related]
33. EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma.
Dang D; Atakilit A; Ramos DM
Anticancer Res; 2008; 28(4B):2049-54. PubMed ID: 18751374
[TBL] [Abstract][Full Text] [Related]
34. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
[TBL] [Abstract][Full Text] [Related]
35. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions.
Sidhu SS; Mengistab AT; Tauscher AN; LaVail J; Basbaum C
Oncogene; 2004 Jan; 23(4):956-63. PubMed ID: 14749763
[TBL] [Abstract][Full Text] [Related]
36. Extracellular matrix metalloproteinase inducer (EMMPRIN) is increased in human left ventricle after acute myocardial infarction.
Nie R; Xie S; Du B; Liu X; Deng B; Wang J
Arch Med Res; 2009 Oct; 40(7):605-11. PubMed ID: 20082877
[TBL] [Abstract][Full Text] [Related]
37. [The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship].
Ouyang YW; Peng ZL; Yao XY; Liu SL; He YD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):330-3. PubMed ID: 15181827
[TBL] [Abstract][Full Text] [Related]
38. Extracellular matrix metalloproteinase inducer in interstitial pneumonias.
Odajima N; Betsuyaku T; Nasuhara Y; Itoh T; Fukuda Y; Senior RM; Nishimura M
Hum Pathol; 2006 Aug; 37(8):1058-65. PubMed ID: 16867869
[TBL] [Abstract][Full Text] [Related]
39. Emmprin in epithelioid sarcoma: expression in tumor cell membrane and stimulation of MMP-2 production in tumor-associated fibroblasts.
Koga K; Nabeshima K; Aoki M; Kawakami T; Hamasaki M; Toole BP; Nakayama J; Iwasaki H
Int J Cancer; 2007 Feb; 120(4):761-8. PubMed ID: 17131322
[TBL] [Abstract][Full Text] [Related]
40. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
